# Isa Mambetsariev

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/isa-mambetsariev/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,736 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 22 |
| i10-index | 41 |
| Last Known Institution | City Of Hope National Medical Center |
| OpenAlex ID | https://openalex.org/A5020914791 |
| ORCID iD | 0000-0003-2882-0249 |
| Works | 112 |

## Researcher papers

- [The Mitochondrion as an Emerging Therapeutic Target in Cancer](https://scholariq.org/papers/the-mitochondrion-as-an-emerging-therapeutic-target-in-cancer/)
- [The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)](https://scholariq.org/papers/the-improbable-targeted-therapy-kras-as-an-emerging-target-in-non-small-cell/)
- [Durvalumab for Stage III EGFR-Mutated NSCLC After Definitive Chemoradiotherapy](https://scholariq.org/papers/durvalumab-for-stage-iii-egfr-mutated-nsclc-after-definitive-chemoradiotherapy/)
- [Integration of artificial intelligence in lung cancer: Rise of the machine](https://scholariq.org/papers/integration-of-artificial-intelligence-in-lung-cancer-rise-of-the-machine/)
- [Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer](https://scholariq.org/papers/acquired-resistance-to-kras-g12c-small-molecule-inhibitors-via-genetic/)
- [Differentiating Peripherally-Located Small Cell Lung Cancer From Non-small Cell Lung Cancer Using a CT Radiomic Approach](https://scholariq.org/papers/differentiating-peripherally-located-small-cell-lung-cancer-from-non-small-cell/)
- [Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastases](https://scholariq.org/papers/radiomic-prediction-of-mutation-status-based-on-mr-imaging-of-lung-cancer-brain/)
- [Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients](https://scholariq.org/papers/exosomal-mirnas-species-in-the-blood-of-small-cell-and-non-small-cell-lung/)
- [Role of immunotherapy and co-mutations on KRAS-mutant non- small cell lung cancer survival](https://scholariq.org/papers/role-of-immunotherapy-and-co-mutations-on-kras-mutant-non-small-cell-lung-cancer/)
- [Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer](https://scholariq.org/papers/predicting-survival-duration-with-mri-radiomics-of-brain-metastases-from-non/)
- [Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase Inhibition](https://scholariq.org/papers/small-cell-transformation-of-egfr-mutant-nsclc-treated-with-tyrosine-kinase/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Researcher university

- [City Of Hope National Medical Center](https://scholariq.org/institutions/city-of-hope-national-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.